Anne-laure L. Leclerc-Sellier
Bron, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
A systematic review of short-term outcomes in patients with anti-factor H associated atypical HUS managed with plasma exchanges versus eculizumab.
Journal: Pediatric nephrology (Berlin, Germany)
Published: January 11, 2026
Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.
Journal: Kidney medicine
Published: November 10, 2025
Don't think that combined liver-kidney transplant can solve everything in primary hyperoxaluria type 1!
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 28, 2025
Antimeningococcal Protection in Patients Receiving Terminal Complement Inhibitors.
Journal: Kidney international reports
Published: July 04, 2025
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 14, 2025
Fine-tuning circulating oxalate levels to improve transplant strategies in primary hyperoxaluria: what is the ideal threshold in pediatrics?
Journal: Nephrologie & therapeutique
Published: March 11, 2025
PHYOX3: Nedosiran Long-Term Safety and Efficacy in Patients With Primary Hyperoxaluria Type 1.
Journal: Kidney international reports
Published: December 20, 2024
Real-Life Data of 2-Year Lumasiran Use in the DAILY-LUMA Cohort.
Journal: Kidney international reports
Published: November 30, 2024
Factors associated with statural growth in pediatric kidney transplant recipients with focus on metabolic acidosis.
Journal: Pediatric nephrology (Berlin, Germany)
Published: October 31, 2024
Last Updated: 09/26/2026